Kane SE - Search Results

1

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer.

Somlo G, Martel CL, Lau SK, Frankel P, Ruel C, Gu L, Hurria A, Chung C, Luu T, Morgan R Jr, Leong L, Koczywas M, McNamara M, Russell CA, Kane SE. Somlo G, et al. Among authors: kane se. Breast Cancer Res Treat. 2012 Feb;131(3):899-906. doi: 10.1007/s10549-011-1850-2. Epub 2011 Nov 1. Breast Cancer Res Treat. 2012. PMID: 22042372 Free PMC article. Clinical Trial.

2

Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.

Gu L, Lau SK, Loera S, Somlo G, Kane SE. Gu L, et al. Among authors: kane se. Clin Cancer Res. 2009 Dec 1;15(23):7196-206. doi: 10.1158/1078-0432.CCR-09-0585. Epub 2009 Nov 17. Clin Cancer Res. 2009. PMID: 19920112 Free PMC article.

3

Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance.

Gu L, Waliany S, Kane SE. Gu L, et al. Among authors: kane se. PLoS One. 2009 Jul 13;4(7):e6220. doi: 10.1371/journal.pone.0006220. PLoS One. 2009. PMID: 19593441 Free PMC article.

4

Differential sensitivities of trastuzumab (Herceptin)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors.

Chan CT, Metz MZ, Kane SE. Chan CT, et al. Among authors: kane se. Breast Cancer Res Treat. 2005 May;91(2):187-201. doi: 10.1007/s10549-004-7715-1. Breast Cancer Res Treat. 2005. PMID: 15868447

5

Bioimaging real-time PXR-dependent mdr1a gene regulation in mdr1a.fLUC reporter mice.

Gu L, Chen J, Synold TW, Forman BM, Kane SE. Gu L, et al. Among authors: kane se. J Pharmacol Exp Ther. 2013 Jun;345(3):438-45. doi: 10.1124/jpet.113.203562. Epub 2013 Mar 26. J Pharmacol Exp Ther. 2013. PMID: 23532932 Free PMC article.

6

t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells.

Lenz G, Hamilton A, Geng S, Hong T, Kalkum M, Momand J, Kane SE, Huss JM. Lenz G, et al. Among authors: kane se. Clin Cancer Res. 2018 Mar 1;24(5):1216-1226. doi: 10.1158/1078-0432.CCR-17-0824. Epub 2017 Nov 27. Clin Cancer Res. 2018. PMID: 29180608 Free PMC article.

7

t-Darpp Promotes Enhanced EGFR Activation and New Drug Synergies in Her2-Positive Breast Cancer Cells.

Denny EC, Kane SE. Denny EC, et al. Among authors: kane se. PLoS One. 2015 Jun 29;10(6):e0132267. doi: 10.1371/journal.pone.0132267. eCollection 2015. PLoS One. 2015. PMID: 26121470 Free PMC article.

8

t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib.

Christenson JL, Denny EC, Kane SE. Christenson JL, et al. Among authors: kane se. Oncotarget. 2015 Oct 20;6(32):33134-45. doi: 10.18632/oncotarget.5311. Oncotarget. 2015. PMID: 26430732 Free PMC article.

9

A new model for studying tissue-specific mdr1a gene expression in vivo by live imaging.

Gu L, Tsark WM, Brown DA, Blanchard S, Synold TW, Kane SE. Gu L, et al. Among authors: kane se. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5394-9. doi: 10.1073/pnas.0807343106. Epub 2009 Mar 12. Proc Natl Acad Sci U S A. 2009. PMID: 19282474 Free PMC article.

10

Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells.

Chen B, Wang Y, Kane SE, Chen S. Chen B, et al. Among authors: kane se. J Mol Endocrinol. 2008 Nov;41(5):367-77. doi: 10.1677/JME-08-0026. Epub 2008 Sep 3. J Mol Endocrinol. 2008. PMID: 18768663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters